================================================================================
EXPERIMENT: baseline_with_formulae
INSTANCE: 60
CALCULATOR: CHA2DS2-VASc Score for Atrial Fibrillation Stroke Risk
TIMESTAMP: 2026-01-02T03:23:03.144350
================================================================================

GROUND TRUTH: 6.0
PREDICTED: 5.0
CORRECT: False


================================================================================
PROMPT
================================================================================

Patient Note:
An 83-year-old male with a history of arterial hypertension and diabetes developed acute right-sided hemiparesis and fluent aphasia (NIHSS score on admission: 4). He arrived at our hospital 45 min later. On admission, his blood pressure was 160/70 mm Hg; atrial fibrillation was detected on electrocardiography. Cranial computed tomography (cCT) revealed no early signs of cerebral ischemia or intracranial hemorrhage (ICH). The patient was unable to self-report his drug history due to persisting aphasia. The INR measured by a commercial POC device was within normal range (1.00; normal 0.85-1.18). IVT (rt-PA 0.9 mg/kg) was initiated 80 min after symptom onset and before all laboratory findings were received. Around 20 min after IVT had commenced, coagulation parameters were normal [including INR (1.10), thrombin time (18.8 s; normal 14-21), partial thromboplastin time (34.8 s, normal 23-36) and platelet counts]. A follow-up cCT ruled out IVT-induced ICH and the patient fully recovered within 48 h (NIHS score: 0). At this stage, he was able to report regular intake of apixaban (EliquisÂ®, 2.5 mg t.i.d.) since April 2014 due to atrial fibrillation. The last apixaban tablet had been taken 13.5 h before IVT.

Question: What is the patient's CHA2DS2-VASc Score? You should use the patient's medical values and health status when they were first admitted to the hospital prior to any treatment.


================================================================================
RESPONSE
================================================================================

5
